SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S. Corbett, Barney S. Graham|Nature|2020Cited by 1.6k
Animal models for COVID-19César Muñoz‐Fontela, Chien‐Te K. Tseng, William E. Dowling et al.|Nature|2020Cited by 877
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Next-generation influenza vaccines: opportunities and challengesChih‐Jen Wei, Gary J. Nabel, Michelle C. Crank et al.|Nature Reviews Drug Discovery|2020Cited by 333
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Barney S. Graham|Nature Communications|2015Cited by 313